针对受调节的细胞死亡:抗癌免疫中的亡,亡,烧亡,铁亡和亡
Ziyu Guo1,2,3,4,5, Yihuang Liu1,2,3,4,5, Danyao Chen6
1Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
Journal of translational internal medicine
|March 21, 2025
概括
准受调细胞死亡 (RCD) 途径,包括细胞亡和铁亡,可以增强抗瘤免疫力. 了解这些细胞死亡机制为癌症治疗和改善瘤微环境提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 调节细胞死亡 (RCD) 途径越来越多地被认为是它们在调节抗瘤免疫力中的作用.
- 接受RCD的瘤细胞可以改变瘤微环境 (TME),可能抑制癌症的进展.
研究的目的:
- 审查各种RCD途径 (亡,亡,烧亡,铁亡,亡) 的机制及其相互作用.
- 讨论RCD如何激活抗原呈现细胞和T细胞,从而触发抗瘤免疫反应.
- 总结针对癌症治疗中的RCD途径的治疗策略.
主要方法:
- 对RCD机制及其对抗瘤免疫力的影响的文献综述.
- 分析RCD在抗原呈现和T细胞激活中的作用.
- 针对RCD通路的药物和纳米颗粒的概述.
主要成果:
- RCD途径影响TME的免疫性,影响癌症的进展.
- 特定的RCD模式激活抗瘤免疫反应的关键组成部分,例如CD8+ T细胞.
- 新的RCD途径为癌症干预提供了新的治疗点.
结论:
- 准RCD途径为增强抗癌免疫提供了有希望的策略.
- 对RCD和TME复杂相互作用的进一步研究对于开发有效的癌症疗法至关重要.
- 了解和操纵RCD对未来的癌症治疗模式具有重大潜力.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
821
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
821
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cells of the Innate Immune Response
1.2K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.2K
The Extrinsic Apoptotic Pathway
5.7K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.7K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


